Cellares Corp. (South San Francisco, Calif.), which is focused on accelerating cell therapy manufacturing, is teaming up with Poseida Therapeutics, Inc. as part of its Early Access Partnership Program (EAPP). Poseida is the third company to join the program after PACT Pharma and Fred Hutchinson Cancer Research Center. “We’ve had relationships with several key stakeholders within Poseida for years,” said…